Literature DB >> 21539707

Determination of the membrane topology of Arv1 and the requirement of the ER luminal region for Arv1 function in Saccharomyces cerevisiae.

Michelle L Villasmil1, Joseph T Nickels.   

Abstract

In Saccharomyces cerevisiae, ARV1 encodes a 321 amino acid transmembrane protein localized to the endoplasmic reticulum (ER) and Golgi. It has been shown previously that arv1 cells harbor defects in sphingolipid and glycosylphosphatidylinositol biosyntheses, and may harbor sterol trafficking defects. Using C-terminal fusion to Suc2-His4, we determined the orientation of full-length Arv1 in the ER membrane. Once membrane topology was determined, we used this information and truncation analysis to establish the minimum protein length required for Arv1 function and phenotypic suppression. By understanding the topology of Arv1 we can now further analyze its putative lipid and glycosylphosphatidylinositol intermediate transport activities.
© 2011 Venenum Biodesign. FEMS Yeast Research © 2011 Federation of European Microbiological Societies. Published by Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21539707     DOI: 10.1111/j.1567-1364.2011.00737.x

Source DB:  PubMed          Journal:  FEMS Yeast Res        ISSN: 1567-1356            Impact factor:   2.796


  8 in total

1.  Arv1 lipid transporter function is conserved between pathogenic and nonpathogenic fungi.

Authors:  Christina Gallo-Ebert; Paula C McCourt; Melissa Donigan; Michelle L Villasmil; WeiWei Chen; Devanshi Pandya; Judith Franco; Desiree Romano; Sean G Chadwick; Scott E Gygax; Joseph T Nickels
Journal:  Fungal Genet Biol       Date:  2011-11-27       Impact factor: 3.495

2.  Topological and mutational analysis of Saccharomyces cerevisiae Fks1.

Authors:  Michael E Johnson; Thomas D Edlind
Journal:  Eukaryot Cell       Date:  2012-05-11

3.  Neuronal deficiency of ARV1 causes an autosomal recessive epileptic encephalopathy.

Authors:  Elizabeth E Palmer; Kelsey E Jarrett; Rani K Sachdev; Fatema Al Zahrani; Mais Omar Hashem; Niema Ibrahim; Hugo Sampaio; Tejaswi Kandula; Rebecca Macintosh; Rajat Gupta; Donna M Conlon; Jeffrey T Billheimer; Daniel J Rader; Kouichi Funato; Christopher J Walkey; Chang Seok Lee; Christine Loo; Susan Brammah; George Elakis; Ying Zhu; Michael Buckley; Edwin P Kirk; Ann Bye; Fowzan S Alkuraya; Tony Roscioli; William R Lagor
Journal:  Hum Mol Genet       Date:  2016-06-06       Impact factor: 6.150

4.  Mice lacking ARV1 have reduced signs of metabolic syndrome and non-alcoholic fatty liver disease.

Authors:  Christina Gallo-Ebert; Jamie Francisco; Hsing-Yin Liu; Riley Draper; Kinnari Modi; Michael D Hayward; Beverly K Jones; Olesia Buiakova; Virginia McDonough; Joseph T Nickels
Journal:  J Biol Chem       Date:  2018-02-28       Impact factor: 5.157

5.  Arv1 regulates PM and ER membrane structure and homeostasis but is dispensable for intracellular sterol transport.

Authors:  Alexander G Georgiev; Jesper Johansen; Vidhya D Ramanathan; Yves Y Sere; Christopher T Beh; Anant K Menon
Journal:  Traffic       Date:  2013-06-06       Impact factor: 6.215

6.  Prohibitin: A Novel Molecular Player in KDEL Receptor Signalling.

Authors:  Monica Giannotta; Giorgia Fragassi; Antonio Tamburro; Capone Vanessa; Alberto Luini; Michele Sallese
Journal:  Biomed Res Int       Date:  2015-05-10       Impact factor: 3.411

7.  Deletion of murine Arv1 results in a lean phenotype with increased energy expenditure.

Authors:  W R Lagor; F Tong; K E Jarrett; W Lin; D M Conlon; M Smith; M Y Wang; B O Yenilmez; M G McCoy; D W Fields; S M O'Neill; R Gupta; A Kumaravel; V Redon; R S Ahima; S L Sturley; J T Billheimer; D J Rader
Journal:  Nutr Diabetes       Date:  2015-10-19       Impact factor: 5.097

8.  Proper Sterol Distribution Is Required for Candida albicans Hyphal Formation and Virulence.

Authors:  Paula McCourt; Hsing-Yin Liu; Josie E Parker; Christina Gallo-Ebert; Melissa Donigan; Adam Bata; Caroline Giordano; Steven L Kelly; Joseph T Nickels
Journal:  G3 (Bethesda)       Date:  2016-11-08       Impact factor: 3.154

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.